BridgeMD
HYSTINDO_Study of the vascularization of the vaginal slice after total laparoscopic hysterectomy, using indocyanine green injection. Prospective feasibility study
EU CTIS ID: 2024-511467-28-00
What this study is testing
Study the presence of indocyanine green at the level of the vaginal slice in surgical treatment by laparoscopic total hysterectomy, in order to evaluate vascularization of the area intraoperatively
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Adult patient
- Patient requiring hysterectomy by surgical treatment accessible by laparoscopy
You likely can't join if
- Protected patient, under guardianship, curatorship or legal protection
- Patient refusal or poor understanding of the French language
- Known allergy to iodine
- Current pregnancy and breastfeeding
- Intervention requiring the use of indocyanine green
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.